Monash Ivf Group Ltd Market Cap ($198.50 Million)
Market Cap & Net Worth: Monash Ivf Group Ltd (MVF)
Monash Ivf Group Ltd market cap. Monash Ivf Group Ltd (AU:MVF) has a market capitalization of $198.50 Million (AU$280.54 Million) as of October 31, 2026. Listed on the AU stock exchange, this Australia-based company holds position #16381 globally and #450 in its home market, demonstrating a -1.37% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Monash Ivf Group Ltd's stock price AU$0.72 by its total outstanding shares 389634840 (389.63 Million).
Monash Ivf Group Ltd Market Cap History (2015–2026)
Monash Ivf Group Ltd market cap history from 2015 to 2026. Data shows change from $278.59 Million to $198.50 Million (-1.43% CAGR). Check Monash Ivf Group Ltd (MVF) share price today for real-time trading data and today's change.
Index Memberships
Monash Ivf Group Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P/ASX 300
AXKO
|
$2.16 Trillion | 0.01% | #253 of 300 |
|
ASX Small Ordinaries
AXSO
|
$284.01 Billion | 0.07% | #161 of 200 |
Weight: Monash Ivf Group Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Monash Ivf Group Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Monash Ivf Group Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see cash flow conversion of Monash Ivf Group Ltd for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.74x
Monash Ivf Group Ltd's market cap is 0.74 times its annual revenue
Latest Price to Earnings (P/E) Ratio
26.73x
Monash Ivf Group Ltd's market cap is 26.73 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $240.27 Million | $155.18 Million | $29.62 Million | 1.55x | 8.11x |
| 2018 | $199.55 Million | $150.64 Million | $21.35 Million | 1.32x | 9.35x |
| 2019 | $219.70 Million | $151.98 Million | $19.85 Million | 1.45x | 11.07x |
| 2020 | $182.62 Million | $145.42 Million | $11.73 Million | 1.26x | 15.57x |
| 2021 | $257.85 Million | $183.60 Million | $25.15 Million | 1.40x | 10.25x |
| 2022 | $243.44 Million | $192.29 Million | $18.41 Million | 1.27x | 13.23x |
| 2023 | $344.86 Million | $213.59 Million | $21.84 Million | 1.61x | 15.79x |
| 2024 | $350.13 Million | $254.96 Million | -$6.53 Million | 1.37x | N/A |
| 2025 | $202.63 Million | $271.92 Million | $25.01 Million | 0.75x | 8.10x |
| 2026 | $198.50 Million | $269.46 Million | $7.42 Million | 0.74x | 26.73x |
Competitor Companies of MVF by Market Capitalization
Companies near Monash Ivf Group Ltd in the global market cap rankings as of October 31, 2026. See net asset quality index of Monash Ivf Group Ltd to understand what proportion of total assets are financed by equity.
Key companies related to Monash Ivf Group Ltd by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #143 globally with a market cap of $164.04 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #480 globally with a market cap of $56.33 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #530 globally with a market cap of $51.40 Billion USD ( CN¥351.23 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $697.00 |
| #143 | Danaher Corporation | NYSE:DHR | $164.04 Billion | $232.23 |
| #480 | Natera Inc | NASDAQ:NTRA | $56.33 Billion | $414.30 |
| #530 | WuXi AppTec Co Ltd | SHG:603259 | $51.40 Billion | CN¥142.01 |
Market Capitalization of Monash Ivf Group Ltd (2015–2026)
Market capitalization of Monash Ivf Group Ltd from 2015 to today. Between 2015 and today, Monash Ivf Group Ltd's market cap moved from $278.59 Million to $ 198.50 Million, with a yearly change of -1.43%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$198.50 Million | -2.04% |
| 2025 | AU$202.63 Million | -42.13% |
| 2024 | AU$350.13 Million | +1.53% |
| 2023 | AU$344.86 Million | +41.66% |
| 2022 | AU$243.44 Million | -5.59% |
| 2021 | AU$257.85 Million | +41.20% |
| 2020 | AU$182.62 Million | -16.88% |
| 2019 | AU$219.70 Million | +10.10% |
| 2018 | AU$199.55 Million | -16.95% |
| 2017 | AU$240.27 Million | -35.26% |
| 2016 | AU$371.14 Million | +33.22% |
| 2015 | AU$278.59 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Monash Ivf Group Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $198.50 Million USD |
| MoneyControl | $198.50 Million USD |
| MarketWatch | $198.50 Million USD |
| marketcap.company | $198.50 Million USD |
| Reuters | $198.50 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Monash Ivf Group Ltd
Monash IVF Group Limited engages in the provision of assisted reproductive genetic and specialist women imaging services in Australia and Southeast Asia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. The company also provides tertiary level prenatal diagnostic, ultrasound, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 a… Read more